ACTIVEAffiliate Disclosure: We may earn commissions from partner links. Details

Editorial Policy

Transparency is a core value at GLP-1 Watchdog. This page explains how we research, write, fact-check, and review every piece of content we publish — and what happens when we get something wrong.

How We Research & Write Content

Every article, review, and guide published on GLP-1 Watchdog follows a structured research process designed to ensure accuracy, completeness, and consumer value.

01

Primary Source Research

We start with primary sources: FDA databases, peer-reviewed clinical trials (PubMed, NEJM, The Lancet), official drug labels, ClinicalTrials.gov entries, and regulatory filings. We never rely on press releases or marketing materials as sole sources.

02

Provider Investigation

For provider reviews, we verify pharmacy licenses through state board databases, check physician credentials via NPI lookup, examine corporate registrations, and conduct mystery shopping to evaluate the real patient experience.

03

Data Cross-Referencing

Key claims are verified against at least two independent sources. Pricing data is verified directly on provider websites and through patient reports. We date-stamp all data points and note when information was last confirmed.

04

Writing & Internal Review

Content is drafted following our author guidelines (below), then reviewed internally for accuracy, clarity, and completeness before advancing to medical review.

Fact-Checking Process

We hold ourselves to the same standard as medical journalism. Every factual claim must meet our sourcing requirements before publication.

Clinical & Medical Claims

  • Must cite a peer-reviewed study, FDA label, or official clinical trial data
  • Preference for randomized controlled trials (RCTs) and systematic reviews
  • Conference abstracts accepted only when clearly labeled as preliminary
  • We link directly to source material whenever available

FDA & Regulatory Claims

  • Sourced from FDA.gov, Federal Register notices, or official warning letters
  • FDA approval dates verified against Drugs@FDA database
  • Enforcement actions confirmed via FDA inspection databases
  • Drug shortage statuses checked against FDA Drug Shortages list

Pricing & Cost Data

  • Verified directly on provider websites within 30 days of publication
  • Manufacturer list prices confirmed via official pricing pages
  • Insurance coverage data sourced from formulary databases
  • All prices include date of last verification

Provider & Company Claims

  • Pharmacy licenses verified through state board of pharmacy databases
  • Physician credentials checked via NPPES NPI Registry
  • Business registrations confirmed through state corporate filings
  • NABP accreditation verified directly with the National Association of Boards of Pharmacy

Medical Review Process

All clinical and health-related content undergoes medical review before publication. Our medical reviewers are board-certified physicians or pharmacists with relevant expertise in endocrinology, obesity medicine, or clinical pharmacology.

Medical reviewers verify clinical accuracy of all health claims

Reviewers flag any statements that could be misleading to patients

Drug interaction information is cross-checked against current prescribing information

Side effect data is validated against FDA adverse event databases (FAERS)

Dosing information is confirmed against official drug labels

Reviewers ensure content does not constitute medical advice — we inform, not prescribe

Important:Content marked “Medical Review Pending” has completed internal fact-checking but has not yet been reviewed by our medical team. We publish time-sensitive content (such as FDA enforcement updates) promptly and prioritize medical review within 48 hours.

Corrections Policy

We take errors seriously. When we get something wrong, we fix it transparently and promptly.

Minor Corrections

Typos, broken links, minor formatting issues, and small factual updates (such as a price change) are corrected inline. The “Updated” date in the article header is refreshed to reflect the change.

Material Corrections

If we publish an incorrect fact that could affect a reader's decision — wrong dosing information, incorrect legal status, misattributed FDA actions — we add a visible correction notice at the top of the article explaining what was wrong and what the correct information is.

Rating Changes

When we update a provider's rating (up or down), we publish a changelog entry explaining why the rating changed and what new information prompted the revision. Historical ratings are preserved for transparency.

Found an error? Email us at corrections@glp1watchdog.com and we will investigate within 24 hours.

Independence from Advertisers

Our editorial content is never influenced by advertising relationships, affiliate partnerships, or provider sponsorships. Period.

Separation of Church and State

Our editorial team operates independently from our business team. Affiliate relationships have zero influence on ratings, rankings, or editorial conclusions.

No Pay-for-Placement

No provider can pay for a higher ranking, a better rating, or preferential coverage. Our scoring methodology is applied uniformly regardless of commercial relationships.

We Show the Cons

Every provider review includes clear downsides, even for providers we have affiliate relationships with. If a provider has problems, readers will know.

Full Disclosure

We disclose all affiliate relationships clearly on every page that contains affiliate links. See our full Affiliate Disclosure for details.

Author Guidelines

All GLP-1 Watchdog contributors follow these standards when creating content:

01
Source everything. Every factual claim must be supported by a credible primary source. If it can't be sourced, it doesn't get published.
02
Write for patients, not physicians. Our audience is consumers making healthcare decisions. Use plain language. Define medical terms. Avoid jargon without explanation.
03
Present both sides. Every medication has risks and benefits. Every provider has pros and cons. Never present a one-sided picture to serve an editorial agenda.
04
Date your data. Prices change, policies evolve, FDA rulings shift. Every time-sensitive data point must include when it was last verified.
05
Disclose conflicts. If an article references a provider we have an affiliate relationship with, it must be disclosed. No exceptions.
06
Never give medical advice. We inform and educate. We never tell readers to start, stop, or change medication. That is between a patient and their doctor.
07
Prioritize safety. When in doubt, err on the side of caution. If there is a safety concern — even an unconfirmed one — flag it clearly for readers.

Questions About Our Editorial Process?

We welcome feedback on our editorial standards and are happy to explain our sourcing for any specific claim.

Email us at editorial@glp1watchdog.com

Find Your GLP-1 Match — Free Quiz